Tag Archives: Multidrug-resistant tuberculosis

TB Elimination: India can Lead the Way

By on .

As the United Nations High Level Meeting on HIV/AIDS gets underway today in New York, Indian Prime Minister Narendra Modi is meeting with Congress this week. Tuberculosis advocates are hoping to see Prime Minister Modi and members of Congress renew their commitment to eliminating TB in India, which has one of the highest TB burdens […]

In stories of Ebola survivors, of MDR TB and poverty, of employment and HIV treatment success . . . We’re reading why science can’t do it alone

By on .

“It never occurred to me I was going to survive . . .”  In a video that is part of a West African multimedia campaign highlighting Ebola survivor’s stories to disseminate information about the virus and its continuing spread, a Guinean woman tells of how six members of her family became sick, how three survived, […]

IDWeek: Update TB strategies to meet global challenges

By on .

PHILADELPHIA, PA- Without new tools, soon, to address multidrug-resistant tuberculosis, TB control efforts made over the last two decades will be defeated, Dr. Carol Dukes Hamilton said this week, in an IDWeek presentation. Hamilton, co-chair of the Infectious Diseases Society of America Center for Global Health Policy called drug-resistant TB a runaway train. New tools are […]

AIDS 2014: HIV and tuberculosis are one disease in Southern Africa

By on .

Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the coming week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – “We must ensure that the worlds of HIV and TB focus on individual human beings instead of individual diseases” This message headlined remarks from Mark […]

$45 million TB cut will not affect “aggregate U.S. support,” Shah says

By on .

But doesn’t explain how  . . . When USAID Administrator Dr. Rajiv Shah went to Congress to discuss the Obama administration’s budget proposal for fiscal year 2015, he began with remarks in which he made no mention of tuberculosis and aside from a mention of “creating an AIDS-free generation,” made no mention of the global […]

WHO guidance on first new TB treatment in five decades offers hope, emphasizes monitoring

By on .

WHO cites need to prevent new drug resistance, protect first treatment advance in more than 40 years The World Health Organization’s release this week of  interim policy guidelines on the use of bedaquiline  for treatment of multidrug-resistant tuberculosis  offers hope to patients and their physicians running out of options to treat the disease, but the […]

TB Week: Survivors and allies recount illness, treatment, and loss

By on .

In the week leading up to International Tuberculosis Day, which commemorates the discovery by Robert Koch of the cause of the disease in 1882, Science Speaks will look at issues, events and efforts to confront this lasting and global health threat. When South African nurse Pat Bond got sick in 2010, doctors treated her for […]

US TB drug shortages highlight global gaps

By on .

This is how small the world of infectious diseases can be, and how recent the distant past. The patient who ended up at Baltimore’s Health Department in April 2011 had been treated with apparent success for tuberculosis before, in Kenya, where he was from. But now, he had a strain of the disease that was […]

Turn up the volume for an all-video edition of What We’re Reading . . .

By on .

Turn up the volume  for these videos on issues that are often surrounded by silence: The reasons for rectal microbicides, the  neglected world of children with tuberculosis, the health consequences of overcrowded prisons, and how infectious diseases travel from prison to tourist when the realities of sex work are left out of an AIDS response. […]

FDA TB drug approval a milestone, with caveats

By on .

The U.S. Food and Drug Administration’s approval of the first new drug to treat tuberculosis in nearly half a century and the agency’s first use of its accelerated approval process to speed availability of TB medicine comes with cautions, and with a direction of work yet to be done, agency officials and treatment advocates agree. […]